ARAT · As filed with the SEC
Arax Holdings cash flow statement, by fiscal year
The statement as Arax Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS (Audited) · USD
| USD | FY2024 Year ended Oct 31, 2024 | FY2023 Year ended Oct 31, 2023 | FY2022 Year ended Oct 31, 2021 | FY2021 Year ended Oct 31, 2021 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | — | — | (131,787) | — |
| Net loss | (3,564,336) | — | — | — |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock based compensation | — | — | 83,834 | 83,834 |
| Changes in accounts receivable | — | (226,951) | — | — |
| Expenses paid by related party | — | — | 11,862 | 11,862 |
| Change in Accrued Liabilities | — | — | 14,150 | 14,150 |
| Change in Accounts Payable | — | (69,293) | — | — |
| Loss on settlement of debt | 103,400 | — | — | — |
| Depreciation Expense | 604 | — | — | — |
| Amortization expense | 65,356 | — | — | — |
| Interest Expense | 377 | — | — | — |
| Equity based compensation expense - stock | 724,862 | — | — | — |
| Impairment loss on Software | 169,373 | — | — | — |
| Provision for Doubtful Accounts (CF) | 226,886 | — | — | — |
| Changes in operating assets and liabilities | ||||
| Accounts receivable- related party, net | (528,636) | — | — | — |
| Change in Accounts Payable | 345,502 | (16,491) | — | — |
| Net cash used in operating activities | (2,456,612) | (18,856,313) | (21,941) | (21,941) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| R&D Software capitalization | — | (5,033,332) | — | — |
| Long-term investments | — | (269,589) | — | — |
| Net cash used in investing activities | — | (5,302,921) | — | — |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Proceeds from Debt Issuance | — | — | 21,941 | 21,941 |
| Additional paid in capital | — | 24,052,178 | — | — |
| Stock Repurchases (Issuances) | — | 115,825 | — | — |
| Common stock to be issued | — | 1,440,000 | — | — |
| Proceeds from Debt Issuance | 1,127,000 | — | — | — |
| Net cash provided by financing activities | 1,127,000 | 25,608,003 | 21,941 | 21,941 |
| Net decrease in cash and cash equivalents | (1,329,612) | 1,448,769 | — | — |
| Cash and cash equivalents, beginning of the year | 1,448,769 | — | — | — |
| Cash and cash equivalents, end of the year | 119,157 | 1,448,769 | — | — |
| Supplemental disclosure of Noncash financing and investing activities: | ||||
| Net Cash from Operating Activities | 268,005 | — | 16,166 | 16,166 |
| Forgiveness of related party debt credited to paid in capital | — | — | — | 5,775 |
| Net Cash from Operating Activities | — | — | 5,775 | — |
| Non-cash proceeds from short-term borrowings | 44,000 | — | — | — |
| Issuance of common stock upon settlement of debt | 147,400 | — | — | — |
| Issuance of common stock for debt treated as a capital contribution | 95,375 | — | — | — |
| Net Income to Common Shareholders | — | (18,543,578) | — | (131,787) |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
